var data={"title":"Cardiovascular problems in the post-anesthesia care unit (PACU)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Cardiovascular problems in the post-anesthesia care unit (PACU)</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/contributors\" class=\"contributor contributor_credentials\">David Broussard, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/contributors\" class=\"contributor contributor_credentials\">Kelly Ural, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/contributors\" class=\"contributor contributor_credentials\">Natalie F Holt, MD, MPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/contributors\" class=\"contributor contributor_credentials\">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/contributors\" class=\"contributor contributor_credentials\">Nancy A Nussmeier, MD, FAHA</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 20, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H260101484\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cardiovascular problems in the post-anesthesia care unit (PACU) include hemodynamic instability due to hypotension, hypertension, or arrhythmias, and complications such as myocardial ischemia or decompensated heart failure. Cardiovascular issues are the third most common problem requiring treatment in the immediate postoperative period, after nausea and vomiting or respiratory problems [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/1-3\" class=\"abstract_t\">1-3</a>].</p><p>The likelihood of cardiovascular problems is related to:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severity of preexisting cardiovascular comorbidities (eg, coronary artery disease, chronic hypertension, congestive heart failure [CHF])</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Invasiveness of the surgical procedure (eg, major vascular, thoracic, abdominal, spine surgery)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severity of perioperative stresses (eg, blood loss, fluid shifts, sepsis, pain, hypothermia)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Effects of anesthetic agents and techniques</p><p/><p>In this topic, we review the rapid diagnosis and treatment of cardiovascular problems in the PACU after noncardiac surgery (eg, hypotension, hypertension, cardiac arrhythmias, myocardial ischemia, and decompensated heart failure). Postoperative complications after cardiac surgery are discussed separately. (See <a href=\"topic.htm?path=postoperative-complications-among-patients-undergoing-cardiac-surgery\" class=\"medical medical_review\">&quot;Postoperative complications among patients undergoing cardiac surgery&quot;</a> and <a href=\"topic.htm?path=atrial-fibrillation-and-flutter-after-cardiac-surgery\" class=\"medical medical_review\">&quot;Atrial fibrillation and flutter after cardiac surgery&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H604297284\"><span class=\"h1\">HYPOTENSION</span></p><p class=\"headingAnchor\" id=\"H30658124\"><span class=\"h2\">Initial assessment and treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypotension may be absolute (eg, systolic blood pressure [BP] &lt;90 mmHg or mean BP &lt;65 mmHg) or relative (eg, systolic BP decrease &gt;20 percent of baseline). These values serve as a guide for treatment, although there is no widely accepted definition of perioperative hypotension [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/4\" class=\"abstract_t\">4</a>]. Hypotension in the post-anesthesia care unit (PACU) is typically treated when the BP is reduced to these values described, or if there is evidence of hypoperfusion (eg, change in mental status or decreased urine output).</p><p>Before treating hypotension, the accuracy of BP measurements should be assessed. Measurements using a noninvasive BP monitor may be inaccurate due to inappropriate cuff size, patient movement, or shivering. Measurements obtained from an intra-arterial catheter may be inaccurate due to technical reasons such as incorrect zeroing or leveling of the pressure transducer, or physiologic reasons such as peripheral arterial stenosis.</p><p>Initial treatment includes intravenous (IV) isotonic crystalloid solution administered in 250- to 500-mL increments. If necessary, IV <span class=\"nowrap\">vasopressor/inotropic</span> agents (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> 40- to 100-mcg increments or <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> 5- to 10-mg increments) are administered to increase BP.</p><p>For severe or refractory hypotension, small bolus doses of diluted IV <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> 10 to 50 mcg, norepinephrine 4 to 16 mcg, or vasopressin 1 to 4 units may be administered, while a <span class=\"nowrap\">vasopressor/inotropic</span> infusion is prepared (<a href=\"image.htm?imageKey=PULM%2F99963\" class=\"graphic graphic_table graphicRef99963 \">table 1</a>).</p><p>A quick assessment often points to an underlying etiology requiring specific treatment:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Major surgical procedures pose a risk for hypovolemia due to large fluid shifts or significant bleeding. (See <a href=\"#H64268415\" class=\"local\">'Hypovolemia'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Review of preoperative medications and anesthetic techniques and drugs may suggest that an antihypertensive drug, residual anesthetic, sympathectomy after neuraxial block, adrenal insufficiency, or an allergic drug reaction is causing hypotension. (See <a href=\"#H30658136\" class=\"local\">'Drug effects'</a> below and <a href=\"#H680092306\" class=\"local\">'Sympathectomy due to neuraxial block'</a> below and <a href=\"#H470507432\" class=\"local\">'Drug allergy and anaphylaxis'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myocardial dysfunction due to myocardial ischemia or decompensated heart failure (HF) is considered in patients at risk for these complications. (See <a href=\"#H64268736\" class=\"local\">'Myocardial dysfunction'</a> below and <a href=\"#H389674433\" class=\"local\">'Myocardial ischemia'</a> below and <a href=\"#H851427634\" class=\"local\">'Decompensated heart failure'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with profound hypotension or cardiovascular collapse may have a condition requiring urgent intervention (eg, anaphylaxis, septic shock, local anesthetic toxicity, tension pneumothorax, pulmonary embolus, pericardial tamponade, dynamic left ventricular outflow tract obstruction). (See <a href=\"#H604297531\" class=\"local\">'Hypotensive emergencies'</a> below.)</p><p/><p class=\"headingAnchor\" id=\"H30659896\"><span class=\"h2\">Treatment of underlying causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to the initial treatment noted above, specific treatment is often necessary after initial assessment has determined the cause(s) of hypotension.</p><p class=\"headingAnchor\" id=\"H64268415\"><span class=\"h3\">Hypovolemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A combination of factors may result in hypovolemia (eg, preoperative fasting resulting in dehydration, diuresis, intraoperative blood loss or fluid shifts, ongoing fluid or blood loss in the postoperative period).</p><p class=\"headingAnchor\" id=\"H414114555\"><span class=\"h4\">Inadequate fluid replacement</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients who have had major surgery or are likely to be dehydrated, we review the intraoperative records to assess blood loss and other fluid losses (eg, preoperative fluid deficit, urine output, fluid shifts), as well as adequacy of intraoperative fluid replacement. If available, central venous pressure (CVP) is measured to assess adequacy of intravascular volume, although it is poorly predictive of fluid responsiveness in many patients [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/5,6\" class=\"abstract_t\">5,6</a>]. (See <a href=\"topic.htm?path=intraoperative-fluid-management#H254314205\" class=\"medical medical_review\">&quot;Intraoperative fluid management&quot;, section on 'Causes of intravascular volume derangements'</a>.)</p><p>If there is evidence of inadequate fluid replacement, we administer IV isotonic crystalloid in 250- to 500-mL boluses and reassess volume status and BP after each bolus.</p><p class=\"headingAnchor\" id=\"H414114473\"><span class=\"h4\">Blood loss</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients who had major surgery, we review estimated intraoperative blood loss versus replacement and measure hemoglobin (Hgb) level.</p><p>However, an individual Hgb value may not accurately reflect blood loss during or immediately after an acute bleeding episode. Also, intraoperative blood loss is commonly underestimated [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/7\" class=\"abstract_t\">7</a>] and may continue into the postoperative period due to circumstances that are case-specific (eg, delayed blood loss after knee surgery with intraoperative use of a tourniquet) or patient-specific (eg, preexisting coagulation disorders). For these reasons, serial measurements may be more useful than a single value.</p><p>For most patients, perioperative red blood cell (RBC) transfusions are administered only if Hgb is &lt;7 to 8 <span class=\"nowrap\">g/dL</span>. Use of this transfusion threshold is generally safe, reduces unnecessary transfusion, and may improve clinical outcomes (<a href=\"image.htm?imageKey=HEME%2F93934\" class=\"graphic graphic_table graphicRef93934 \">table 2</a>). (See <a href=\"topic.htm?path=intraoperative-transfusion-of-blood-products-in-adults#H2495218495\" class=\"medical medical_review\">&quot;Intraoperative transfusion of blood products in adults&quot;, section on 'Red blood cells'</a>.)</p><p class=\"headingAnchor\" id=\"H30658136\"><span class=\"h3\">Drug effects</span></p><p class=\"headingAnchor\" id=\"H30658180\"><span class=\"h4\">Antihypertensive agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Effects of chronically or recently administered antihypertensive agents may cause hypotension. Intraoperative administration of longer-acting IV agents (eg, <a href=\"topic.htm?path=hydralazine-drug-information\" class=\"drug drug_general\">hydralazine</a>, <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a>, or <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a>) may result in postoperative hypotension once painful surgical stimulation has ceased.</p><p>Treatment is administration of <span class=\"nowrap\">vasopressor/inotropic</span> agents (see <a href=\"#H30658124\" class=\"local\">'Initial assessment and treatment'</a> above). It is also necessary to treat bradycardia (due to the negative chronotropic effects of an antihypertensive drug) if this is contributing to hypotension. (See <a href=\"#H604297436\" class=\"local\">'Bradycardia'</a> below.)</p><p class=\"headingAnchor\" id=\"H470507396\"><span class=\"h4\">Anesthetic agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Residual effects of anesthetic agents or excessive opioid doses may result in hypotension, particularly in patients who have little pain after surgery. Such patients are typically somnolent or obtunded, as well as hypotensive.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Benzodiazepines </strong>&ndash; If excessive benzodiazepine dosing is suspected, IV <a href=\"topic.htm?path=flumazenil-drug-information\" class=\"drug drug_general\">flumazenil</a> may be administered in 0.2-mg increments up to a maximum dose of 3 mg within any one hour, which typically hastens emergence from anesthesia, with resolution of hypotension [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/8\" class=\"abstract_t\">8</a>]. (See <a href=\"topic.htm?path=benzodiazepine-poisoning-and-withdrawal#H14\" class=\"medical medical_review\">&quot;Benzodiazepine poisoning and withdrawal&quot;, section on 'Antidote (flumazenil)'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Opioids</strong> &ndash; If excessive opioid dosing is suspected, IV <a href=\"topic.htm?path=naloxone-drug-information\" class=\"drug drug_general\">naloxone</a> 40 mcg may be administered every five minutes until the sedative and respiratory depressant effects are reversed, typically with resolution of hypotension. The half-life of naloxone is 1 to 1.5 hours, which may be shorter than the half-life of the opioid being reversed. In these instances, repeat doses of naloxone may be administered, or a continuous infusion may be started at 0.5 to 1 <span class=\"nowrap\">mcg/kg/hour</span>. (See <a href=\"topic.htm?path=acute-opioid-intoxication-in-adults#H13\" class=\"medical medical_review\">&quot;Acute opioid intoxication in adults&quot;, section on 'Management'</a>.)</p><p/><p class=\"bulletIndent1\">Titration of such low doses of <a href=\"topic.htm?path=naloxone-drug-information\" class=\"drug drug_general\">naloxone</a> safely reverses opioid effects in most patients. Rarely, sudden reversal of analgesic effects causes extreme discomfort and a sympathetic surge resulting in hypertension, tachycardia, and myocardial ischemia (see <a href=\"#H389674433\" class=\"local\">'Myocardial ischemia'</a> below). Flash pulmonary edema has also been reported after a large dose of naloxone [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/9\" class=\"abstract_t\">9</a>].</p><p/><p>Intraoperative administration of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>, <a href=\"topic.htm?path=dexmedetomidine-drug-information\" class=\"drug drug_general\">dexmedetomidine</a>, <span class=\"nowrap\">and/or</span> inhalational anesthetic agents are unlikely to cause postoperative hypotension because these agents are short-acting.</p><p class=\"headingAnchor\" id=\"H680092306\"><span class=\"h3\">Sympathectomy due to neuraxial block</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sympathectomy due to high neuraxial anesthetic block may result in hypotension. This is more likely when the sensory block is above the T6 level and when local anesthetics are infused through the epidural catheter. It is also more likely in patients with preexisting hypertension [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/10\" class=\"abstract_t\">10</a>].</p><p>If hypotension does not resolve after initial therapy with IV fluid boluses and <span class=\"nowrap\">vasopressor/inotropic</span> agents (see above), any ongoing neuraxial infusion of local anesthetic is decreased or temporarily discontinued, or the infusion is changed to contain only an opiate. Also, the location of the epidural catheter is confirmed with aspiration to ensure that the tip has not migrated to enter a blood vessel or the intrathecal space. If the epidural catheter is malpositioned, it should be removed.</p><p class=\"headingAnchor\" id=\"H292870340\"><span class=\"h3\">Allergic (hypersensitivity) reaction</span></p><p class=\"headingAnchor\" id=\"H470507432\"><span class=\"h4\">Drug allergy and anaphylaxis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Postoperative hypotension may occur due to exposure to latex or a medication administered during or after surgery. Perioperative medications commonly causing allergic reactions include antibiotics and protamine [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/11,12\" class=\"abstract_t\">11,12</a>]. Allergic reactions typically present as itching and as a rash or hives, but these minor symptoms may not be noticed by a patient with residual postoperative sedation. (See <a href=\"topic.htm?path=perioperative-anaphylaxis-clinical-manifestations-etiology-and-management#H4\" class=\"medical medical_review\">&quot;Perioperative anaphylaxis: Clinical manifestations, etiology, and management&quot;, section on 'Etiologies'</a> and <a href=\"topic.htm?path=perioperative-anaphylaxis-clinical-manifestations-etiology-and-management#H14\" class=\"medical medical_review\">&quot;Perioperative anaphylaxis: Clinical manifestations, etiology, and management&quot;, section on 'Clinical manifestations and diagnosis'</a>.)</p><p>Treatment for anaphylaxis is initiated immediately if the rash is accompanied by any evidence of hypotension, bronchospasm, oral or facial edema, or inspiratory stridor. Management of perioperative anaphylaxis is discussed in detail separately. (See <a href=\"topic.htm?path=anaphylaxis-emergency-treatment\" class=\"medical medical_review\">&quot;Anaphylaxis: Emergency treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H443892235\"><span class=\"h4\">Transfusion reaction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Typical signs and symptoms of acute transfusion reaction are fever, chills, pruritus, and urticaria. If a hemolytic or anaphylactic transfusion reaction is suspected as the cause of hypotension during a transfusion, the transfusion is stopped and IV fluids and <span class=\"nowrap\">vasopressor/inotropic</span> agents are administered. Standard treatment is initiated for a mild allergic reaction or for a more severe anaphylactic reaction, as appropriate (see <a href=\"#H470507432\" class=\"local\">'Drug allergy and anaphylaxis'</a> above). The blood bank should be notified to determine the cause of the reaction. (See <a href=\"topic.htm?path=approach-to-the-patient-with-a-suspected-acute-transfusion-reaction\" class=\"medical medical_review\">&quot;Approach to the patient with a suspected acute transfusion reaction&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H443893336\"><span class=\"h3\">Adrenal insufficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute adrenal insufficiency may occur in a patient who was receiving chronic glucocorticoid therapy but did not receive adequate perioperative replacement therapy. While uncommon, adrenal insufficiency is suspected in a patient on chronic therapy, particularly if hypotension is refractory to standard treatment with fluids and vasopressors. In such cases, IV <a href=\"topic.htm?path=hydrocortisone-drug-information\" class=\"drug drug_general\">hydrocortisone</a> 100 mg or <a href=\"topic.htm?path=dexamethasone-drug-information\" class=\"drug drug_general\">dexamethasone</a> 4 mg is administered, in addition to standard treatment with IV fluids and <span class=\"nowrap\">vasopressor/inotropic</span> agents. (See <a href=\"topic.htm?path=treatment-of-adrenal-insufficiency-in-adults#H2\" class=\"medical medical_review\">&quot;Treatment of adrenal insufficiency in adults&quot;, section on 'Adrenal crisis'</a>.)</p><p class=\"headingAnchor\" id=\"H64268736\"><span class=\"h3\">Myocardial dysfunction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute myocardial ischemia or perioperative decompensation of preexisting HF may result in myocardial dysfunction severe enough to cause hypotension. (See <a href=\"#H389674433\" class=\"local\">'Myocardial ischemia'</a> below and <a href=\"#H851427634\" class=\"local\">'Decompensated heart failure'</a> below.)</p><p class=\"headingAnchor\" id=\"H604297531\"><span class=\"h2\">Hypotensive emergencies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Conditions that cause profound hypotension <span class=\"nowrap\">and/or</span> hemodynamic collapse require immediate lifesaving interventions. Support with <span class=\"nowrap\">vasopressor/inotropic</span> agents is provided (<a href=\"image.htm?imageKey=PULM%2F99963\" class=\"graphic graphic_table graphicRef99963 \">table 1</a>) while definitive treatment is underway (see <a href=\"#H30658124\" class=\"local\">'Initial assessment and treatment'</a> above). Appropriate specialists are consulted to continue management <span class=\"nowrap\">and/or</span> intensive care after the patient is stabilized and discharged from the PACU.</p><p>The cardinal features of these conditions are summarized below to provide assistance in identifying a likely diagnosis.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Septic shock</strong> &ndash; Sepsis may be preexisting before surgery, or may develop during or after surgery in patients with active infection. Sepsis should be suspected in susceptible patients with tachycardia and profound hypotension due to vasodilation (with high cardiac output if intravascular volume is adequate). IV fluids and vasopressor infusion(s) (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>, norepinephrine, <span class=\"nowrap\">and/or</span> vasopressin (<a href=\"image.htm?imageKey=PULM%2F99963\" class=\"graphic graphic_table graphicRef99963 \">table 1</a>)) are administered in the PACU to stabilize the patient. Also, since early administration of antibiotics is critical for management of patients with severe sepsis and septic shock, the surgeon <span class=\"nowrap\">and/or</span> an infectious disease specialist are consulted to ensure that antibiotic coverage is appropriate and appropriate cultures are sent for testing. (See <a href=\"topic.htm?path=evaluation-and-management-of-suspected-sepsis-and-septic-shock-in-adults\" class=\"medical medical_review\">&quot;Evaluation and management of suspected sepsis and septic shock in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Local anesthetic toxicity </strong>&ndash; Local anesthetic toxicity causes profound hypotension and arrhythmias (eg, bradycardia, atrioventricular block, ventricular arrhythmias). This may occur in the postoperative period due to intravascular location of a misplaced epidural or peripheral nerve catheter or, rarely, due to accidental IV administration of a local anesthetic infusion intended for epidural or perineural administration. Central nervous system symptoms (eg, ringing in the ears, metallic taste, tingling of the lips, agitation, seizures) commonly precede signs of cardiovascular toxicity. Treatment is discussed separately. (See <a href=\"topic.htm?path=overview-of-peripheral-nerve-blocks#H1299279043\" class=\"medical medical_review\">&quot;Overview of peripheral nerve blocks&quot;, section on 'Local anesthetic systemic toxicity'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Tension pneumothorax </strong>&ndash; Tension pneumothorax is suspected in patients with hypotension, dyspnea, tachypnea, worsening oxygenation, chest pain, distended neck veins, tracheal deviation, or risk factors that include attempted or actual central line insertion, surgery in the neck or thorax, or chronic lung disease. Treatment of tension pneumothorax is emergent needle decompression. (See <a href=\"topic.htm?path=evaluation-of-and-initial-approach-to-the-adult-patient-with-undifferentiated-hypotension-and-shock#H458581248\" class=\"medical medical_review\">&quot;Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock&quot;, section on 'Tension pneumothorax'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pulmonary embolus </strong>&ndash; Pulmonary embolus (PE) is suspected in hypotensive patients with acute onset of shortness of breath, tachycardia, and hypoxia. Specific details for management of patients with hemodynamically unstable PE are discussed elsewhere (<a href=\"image.htm?imageKey=PULM%2F99762\" class=\"graphic graphic_algorithm graphicRef99762 \">algorithm 1</a>). (See <a href=\"topic.htm?path=treatment-prognosis-and-follow-up-of-acute-pulmonary-embolism-in-adults#H276577990\" class=\"medical medical_review\">&quot;Treatment, prognosis, and follow-up of acute pulmonary embolism in adults&quot;, section on 'Hemodynamically unstable'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cardiac tamponade </strong>&ndash; Cardiac tamponade is suspected in patients with dyspnea, tachycardia, hypotension, elevated jugular venous pressure, distant heart sounds, pulsus paradoxus, and known risk factors (eg, trauma, recent thoracic or pericardial procedure, prior pericardial effusion). Urgent echocardiography is used to confirm the diagnosis and guide immediate treatment. (See <a href=\"topic.htm?path=cardiac-tamponade\" class=\"medical medical_review\">&quot;Cardiac tamponade&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dynamic left ventricular outflow tract obstruction</strong> &ndash; Dynamic left ventricular outflow tract (LVOT) obstruction associated with hypotension and mitral regurgitation can be precipitated by hypovolemia, vasodilation, tachycardia, <span class=\"nowrap\">and/or</span> a high catecholamine state in susceptible patients, usually those with hypertrophic cardiomyopathy. Rapid diagnosis is possible with echocardiography. Specific management of LVOT obstruction is described separately. (See <a href=\"topic.htm?path=hypertrophic-cardiomyopathy-medical-therapy#H4268009218\" class=\"medical medical_review\">&quot;Hypertrophic cardiomyopathy: Medical therapy&quot;, section on 'Acute hemodynamic collapse in the setting of LVOT obstruction'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H604297382\"><span class=\"h1\">HYPERTENSION</span></p><p class=\"headingAnchor\" id=\"H30658945\"><span class=\"h2\">Initial assessment and treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypertension occurring in the post-anesthesia care unit (PACU) is typically treated if systolic blood pressure (BP) is &gt;180 mmHg or diastolic BP is &gt;110 mmHg, particularly if hypertension is persistent after treatment of presumed etiologies. (See <a href=\"topic.htm?path=perioperative-management-of-hypertension#H16\" class=\"medical medical_review\">&quot;Perioperative management of hypertension&quot;, section on 'Indications for and approach to therapy'</a>.)</p><p>Before treating hypertension, we review the patient's preoperative and baseline BP, as well as the home medication list and timing of last doses of antihypertensive medications. Treatment thresholds for patients who had severe preoperative hypertension (ie, <span class=\"nowrap\">&ge;180/&ge;120</span> mmHg) may vary, and are discussed separately. (See <a href=\"topic.htm?path=management-of-severe-asymptomatic-hypertension-hypertensive-urgencies-in-adults\" class=\"medical medical_review\">&quot;Management of severe asymptomatic hypertension (hypertensive urgencies) in adults&quot;</a>.)</p><p>If patients are due for a dose of their usual antihypertensive medication(s), oral doses of those medications may be administered as initial treatment. If response is inadequate or if oral administration of medications is not feasible, then small doses of rapid-acting intravenous (IV) antihypertensive agents are administered. Typically, <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a> 5 to 20 mg, <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a> 1 to 5 mg, <a href=\"topic.htm?path=hydralazine-drug-information\" class=\"drug drug_general\">hydralazine</a> 5 to 10 mg, or <a href=\"topic.htm?path=nicardipine-drug-information\" class=\"drug drug_general\">nicardipine</a> 0.2-mg increments are titrated to decrease systolic BP to a consistent value &lt;160 mmHg. Since metoprolol and labetalol have beta-blocking properties, these agents are preferred if hypertension is associated with tachycardia [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/13,14\" class=\"abstract_t\">13,14</a>].</p><p>Additional treatment of hypertension depends upon the specific etiology. (See <a href=\"#H30660184\" class=\"local\">'Treatment of underlying causes'</a> below.)</p><p class=\"headingAnchor\" id=\"H1047418413\"><span class=\"h2\">Hypertensive emergencies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Emergency treatment of severe hypertension is warranted if there is evidence of acute neurologic signs or symptoms (eg, agitation, delirium, stupor, visual disturbances, seizures, stroke), a cardiovascular emergency (eg, acute coronary syndrome, acute decompensated heart failure [HF], aortic dissection), or renal injury (eg, hematuria, rising creatinine). (See <a href=\"topic.htm?path=evaluation-and-treatment-of-hypertensive-emergencies-in-adults\" class=\"medical medical_review\">&quot;Evaluation and treatment of hypertensive emergencies in adults&quot;</a>.)</p><p>Rarely, a pheochromocytoma may cause severe hypertension, typically associated with tachycardia, arrhythmias, <span class=\"nowrap\">and/or</span> cardiovascular collapse [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/15,16\" class=\"abstract_t\">15,16</a>]. Risks are particularly high when pheochromocytoma is previously undiagnosed; mortality in this setting approaches 80 percent [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/17\" class=\"abstract_t\">17</a>]. (See <a href=\"topic.htm?path=anesthesia-for-the-adult-with-pheochromocytoma\" class=\"medical medical_review\">&quot;Anesthesia for the adult with pheochromocytoma&quot;</a>.)</p><p>The IV drugs used for emergency treatment of severe hypertension are discussed in detail elsewhere (<a href=\"image.htm?imageKey=NEPH%2F64066\" class=\"graphic graphic_table graphicRef64066 \">table 3</a>). (See <a href=\"topic.htm?path=drugs-used-for-the-treatment-of-hypertensive-emergencies\" class=\"medical medical_review\">&quot;Drugs used for the treatment of hypertensive emergencies&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H30660184\"><span class=\"h2\">Treatment of underlying causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to the initial treatment noted above, specific treatment is often necessary after initial assessment has determined the cause(s) of hypertension.</p><p class=\"headingAnchor\" id=\"H416807755\"><span class=\"h3\">Preexisting hypertension</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Undiagnosed or poorly controlled preexisting hypertension is the most common cause of perioperative hypertension, particularly if the patient's chronically administered antihypertensive medications were not continued up until the time of surgery [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/18-22\" class=\"abstract_t\">18-22</a>]. In particular, withdrawal syndromes with rebound hypertension can occur with medications such as <a href=\"topic.htm?path=clonidine-drug-information\" class=\"drug drug_general\">clonidine</a> and beta blockers. (See <a href=\"topic.htm?path=perioperative-management-of-hypertension#H12\" class=\"medical medical_review\">&quot;Perioperative management of hypertension&quot;, section on 'Withdrawal syndromes'</a> and <a href=\"topic.htm?path=perioperative-management-of-hypertension#H17\" class=\"medical medical_review\">&quot;Perioperative management of hypertension&quot;, section on 'Choice of drugs'</a>.)</p><p class=\"headingAnchor\" id=\"H604297388\"><span class=\"h3\">Noxious stimuli</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pain </strong>&ndash; Inadequately treated pain is a common cause of sympathetic stimulation resulting in hypertension and tachycardia in the PACU, particularly after major invasive surgical procedures. Details regarding management of acute postoperative pain are discussed separately. (See <a href=\"topic.htm?path=management-of-acute-perioperative-pain\" class=\"medical medical_review\">&quot;Management of acute perioperative pain&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Nausea and vomiting </strong>&ndash; Postoperative nausea and vomiting (PONV) is the most common complication occurring in the PACU, and the associated sympathetic stimulation may cause hypertension <span class=\"nowrap\">and/or</span> tachycardia [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/1\" class=\"abstract_t\">1</a>]. Therapy is directed at treating this primary problem; details are available elsewhere. (See <a href=\"topic.htm?path=overview-of-post-anesthetic-care-for-adult-patients#H1324456782\" class=\"medical medical_review\">&quot;Overview of post-anesthetic care for adult patients&quot;, section on 'Postoperative nausea and vomiting'</a> and <a href=\"topic.htm?path=postoperative-nausea-and-vomiting\" class=\"medical medical_review\">&quot;Postoperative nausea and vomiting&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hypoxia <span class=\"nowrap\">and/or</span> hypercarbia </strong>&ndash; Respiratory problems causing hypoxia <span class=\"nowrap\">and/or</span> hypercarbia are the second most common complication occurring in the PACU and may be accompanied by hypertension <span class=\"nowrap\">and/or</span> tachycardia due to sympathetic stimulation [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/1\" class=\"abstract_t\">1</a>]. Details regarding causes and management of respiratory problems in this setting are available elsewhere. (See <a href=\"topic.htm?path=respiratory-problems-in-the-post-anesthesia-care-unit-pacu\" class=\"medical medical_review\">&quot;Respiratory problems in the post-anesthesia care unit (PACU)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Delirium and agitation</strong> &ndash; Emergence delirium with agitation, hyperexcitation, or confusion occurs in up to 5 percent of adult patients after general anesthesia and may be accompanied by hypertension <span class=\"nowrap\">and/or</span> tachycardia [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/23,24\" class=\"abstract_t\">23,24</a>]. Treatment is discussed separately. (See <a href=\"topic.htm?path=delayed-emergence-and-emergence-delirium-in-adults#H1942104686\" class=\"medical medical_review\">&quot;Delayed emergence and emergence delirium in adults&quot;, section on 'Emergence delirium'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hypothermia with shivering </strong>&ndash; Hypothermia results in patient discomfort and sympathetic stimulation with hypertension <span class=\"nowrap\">and/or</span> tachycardia, as well as markedly increased myocardial O<sub>2</sub> consumption due to shivering [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/25-27\" class=\"abstract_t\">25-27</a>]. In patients with ischemic heart disease, these may lead to myocardial ischemia and arrhythmias [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/28,29\" class=\"abstract_t\">28,29</a>]. Concurrent priorities include treatment of hypothermia itself and treatment of shivering (see <a href=\"topic.htm?path=overview-of-post-anesthetic-care-for-adult-patients#H816154108\" class=\"medical medical_review\">&quot;Overview of post-anesthetic care for adult patients&quot;, section on 'Hypothermia or hyperthermia'</a>). Severe or persistent hypertension is addressed after initial treatment of hypothermia and shivering. (See <a href=\"#H30658945\" class=\"local\">'Initial assessment and treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Bladder distention </strong>&ndash; A distended bladder is a common and often overlooked cause of sympathetic stimulation and hypertension in the PACU, particularly in patients with recent anorectal surgery, neuraxial block, excess intraoperative fluid administration, or a history of urinary retention [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/30,31\" class=\"abstract_t\">30,31</a>]. Patients with &gt;600 mL of urine noted on bladder ultrasound are treated with one-time catheterization. (See <a href=\"topic.htm?path=overview-of-post-anesthetic-care-for-adult-patients#H154735179\" class=\"medical medical_review\">&quot;Overview of post-anesthetic care for adult patients&quot;, section on 'Inability to void'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H307120786\"><span class=\"h3\">Hypervolemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Volume overload due to intraoperative fluid or blood administration may result in postoperative hypertension. Initial therapy is administration of an IV diuretic, typically <a href=\"topic.htm?path=furosemide-drug-information\" class=\"drug drug_general\">furosemide</a> 20 to 40 mg, in addition to treatment of hypertension. Vasodilator therapy (eg, IV <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a> or <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> infusions) (<a href=\"image.htm?imageKey=NEPH%2F64066\" class=\"graphic graphic_table graphicRef64066 \">table 3</a>) may be necessary to lower BP if hypervolemic hypertension is severe or associated with acute decompensated HF. (See <a href=\"topic.htm?path=treatment-of-acute-decompensated-heart-failure-components-of-therapy#H4\" class=\"medical medical_review\">&quot;Treatment of acute decompensated heart failure: Components of therapy&quot;, section on 'Diuretics'</a> and <a href=\"topic.htm?path=treatment-of-acute-decompensated-heart-failure-components-of-therapy#H1059927093\" class=\"medical medical_review\">&quot;Treatment of acute decompensated heart failure: Components of therapy&quot;, section on 'Vasodilator therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H924151517\"><span class=\"h3\">Use of alcohol, opioids, and other drugs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients chronically using alcohol or opioids may develop hypertension <span class=\"nowrap\">and/or</span> tachycardia in the PACU due to sympathetic stimulation associated with withdrawal. Severe hypertension may develop in patients who have recently used any drug that causes a hyperadrenergic response (eg, cocaine, amphetamine, phencyclidine, or a monoamine oxidase inhibitor).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Alcohol withdrawal </strong>&ndash; Symptoms of alcohol withdrawal (eg, hypertension, tachycardia, tremulousness, sweating, nausea, anxiety) may manifest as early as 6 to 24 hours after the last drink and can progress to delirium tremens with worsening hypertension in 48 to 96 hours. Benzodiazepines (eg, IV <a href=\"topic.htm?path=lorazepam-drug-information\" class=\"drug drug_general\">lorazepam</a>) are administered to treat withdrawal symptoms. Management of alcohol withdrawal is discussed separately. (See <a href=\"topic.htm?path=management-of-moderate-and-severe-alcohol-withdrawal-syndromes\" class=\"medical medical_review\">&quot;Management of moderate and severe alcohol withdrawal syndromes&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Opioid withdrawal </strong>&ndash; Symptoms of opioid withdrawal (eg, hypertension, tachycardia, mydriasis, piloerection, nausea, dysphoria) typically begin 6 to 12 hours after the last opioid dose. Management of opioid withdrawal is discussed separately. (See <a href=\"topic.htm?path=opioid-withdrawal-in-the-emergency-setting\" class=\"medical medical_review\">&quot;Opioid withdrawal in the emergency setting&quot;</a> and <a href=\"topic.htm?path=management-of-acute-perioperative-pain#H795596667\" class=\"medical medical_review\">&quot;Management of acute perioperative pain&quot;, section on 'Opioid-dependent patients'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Recent cocaine, amphetamine, or phencyclidine use </strong>&ndash; Recent use of drugs that produce a hyperadrenergic state (eg, cocaine, amphetamine, phencyclidine, or a monoamine oxidase inhibitor) can cause sympathetic overactivity and hypertension, tachycardia, and cardiac arrhythmias. In these patients, administration of a sympathomimetic agent may precipitate severe hypertension or a cardiovascular or neurologic emergency requiring immediate treatment. (See <a href=\"#H1047418413\" class=\"local\">'Hypertensive emergencies'</a> above.)</p><p/><p class=\"bulletIndent1\">Further details regarding management of cardiovascular complications of these drugs may be found elsewhere:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>(See <a href=\"topic.htm?path=cocaine-acute-intoxication#H11\" class=\"medical medical_review\">&quot;Cocaine: Acute intoxication&quot;, section on 'Cardiovascular complications'</a>.)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>(See <a href=\"topic.htm?path=acute-amphetamine-and-synthetic-cathinone-bath-salt-intoxication#H1392805\" class=\"medical medical_review\">&quot;Acute amphetamine and synthetic cathinone (&quot;bath salt&quot;) intoxication&quot;, section on 'Hypertension'</a>.)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>(See <a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-adults#H18\" class=\"medical medical_review\">&quot;Phencyclidine (PCP) intoxication in adults&quot;, section on 'Treatment of complications'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H604297430\"><span class=\"h1\">CARDIAC ARRHYTHMIAS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most arrhythmias noted in the post-anesthesia care unit (PACU) are transient and clinically insignificant. However, the appearance of a new arrhythmia may indicate myocardial ischemia in a patient with preexisting cardiovascular disease [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/21\" class=\"abstract_t\">21</a>]. (See <a href=\"#H389674433\" class=\"local\">'Myocardial ischemia'</a> below.)</p><p>Proper lead placement for the electrocardiogram (ECG) should be confirmed, and a 12-lead ECG is obtained as soon as feasible in a patient with a new arrhythmia. Contributing causes should be identified and treated (eg, hypoxemia, hypoventilation, acidemia, anemia, electrolyte abnormalities). In particular, hypokalemia should be identified and corrected immediately. (See <a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-hypokalemia-in-adults#H18820461\" class=\"medical medical_review\">&quot;Clinical manifestations and treatment of hypokalemia in adults&quot;, section on 'Intravenous potassium repletion'</a>.)</p><p>A severe bradyarrhythmia or tachyarrhythmia may cause hemodynamic instability or cardiac arrest. Management of arrhythmias in unstable patients is summarized below and discussed in detail separately [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/32\" class=\"abstract_t\">32</a>]. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H7\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Management of specific arrhythmias'</a>.)</p><p class=\"headingAnchor\" id=\"H604297436\"><span class=\"h2\">Bradycardia</span></p><p class=\"headingAnchor\" id=\"H30659091\"><span class=\"h3\">Initial treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Severe bradycardia (heart rate [HR] &lt;40 <span class=\"nowrap\">beats/minute</span> [bpm]) in an unstable patient (eg, hypotension, altered mental status) is initially treated with intravenous (IV) <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a> 0.5 mg; this dose is repeated every three to five minutes up to a total of 3 mg (<a href=\"image.htm?imageKey=EM%2F63919\" class=\"graphic graphic_algorithm graphicRef63919 \">algorithm 2</a>). Further management of bradycardia is discussed separately. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H11\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Bradycardia'</a>.)</p><p>Severe bradycardia (HR &lt;40 bpm) in a patient who is stable or has less severe symptoms may be initially treated with IV <a href=\"topic.htm?path=glycopyrrolate-glycopyrronium-drug-information\" class=\"drug drug_general\">glycopyrrolate</a> in 0.2-mg increments up to 1 mg <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> in 5 to 10 mg increments, since <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a> may cause undesirable tachycardia (eg, in patients with ischemic heart disease) or altered mental status (eg, in elderly patients).</p><p>Mild sinus bradycardia (ie, HR 40 to 60 bpm) that remains stable in an asymptomatic patient does not require treatment. (See <a href=\"topic.htm?path=sinus-bradycardia\" class=\"medical medical_review\">&quot;Sinus bradycardia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H30659097\"><span class=\"h3\">Assessment and treatment of underlying causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For bradycardia occurring in the PACU, we review the following potential causes and institute appropriate specific therapy:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Medications</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Negative chronotropic agents</strong> &ndash; A beta blocker or other negative chronotropic agent (eg, calcium channel blockers, <a href=\"topic.htm?path=digoxin-drug-information\" class=\"drug drug_general\">digoxin</a>, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>) is the most common cause of postoperative bradycardia. In patients with ischemic heart disease, these drugs are administered (chronically or recently) to maintain HR in the range of 50 to 80 bpm. For these patients, baseline (admission) HR is noted, and bradycardia is treated only if it is severe (HR &lt;40 bpm) or if symptoms develop. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H213850611\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Prevention of ischemia'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Anticholinesterase agents </strong>&ndash; Bradycardia in the PACU may be caused by the muscarinic effects of an acetylcholinesterase inhibitor (eg, <a href=\"topic.htm?path=neostigmine-drug-information\" class=\"drug drug_general\">neostigmine</a> or <a href=\"topic.htm?path=edrophonium-drug-information\" class=\"drug drug_general\">edrophonium</a>) used for reversal of nondepolarizing neuromuscular blocking agents (NMBAs) near the end of surgery. The anesthesia record is reviewed to determine if the patient received an acetylcholinesterase inhibitor administered with an adequate dose of anticholinergic agent (eg, <a href=\"topic.htm?path=glycopyrrolate-glycopyrronium-drug-information\" class=\"drug drug_general\">glycopyrrolate</a> or <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a>). If underdosing of the anticholinergic agent is suspected, an additional dose of IV glycopyrrolate 0.2 mg or atropine 0.4 mg is administered and may be repeated. (See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Neuraxial anesthesia</strong> &ndash; Neuraxial anesthesia with a T1 to T4 anesthetic level may cause bradycardia and hypotension [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/33-36\" class=\"abstract_t\">33-36</a>]. Although <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a> may be administered, bradycardia caused by blockade of the cardiac accelerator fibers responds best to beta-adrenergic agonists (eg, <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> 5 to 10 mg or, if severe, <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> 10 to 20 mcg, titrated to effect, then followed by an epinephrine infusion if the bradycardia is persistent (<a href=\"image.htm?imageKey=PULM%2F99963\" class=\"graphic graphic_table graphicRef99963 \">table 1</a>)). Also, the epidural infusion is reduced or temporarily discontinued.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Adverse perioperative events</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Hypoxia</strong> &ndash; Hypoxia inactivates pacemaker channels, leading to a reduction in the pacemaker rate of the sinoatrial node and consequent bradycardia. (See <a href=\"topic.htm?path=respiratory-problems-in-the-post-anesthesia-care-unit-pacu\" class=\"medical medical_review\">&quot;Respiratory problems in the post-anesthesia care unit (PACU)&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Myocardial ischemia</strong> &ndash; Sinus bradycardia occurs in 15 to 25 percent of patients having an acute myocardial infarction, particularly if ischemia involves the right coronary artery. (See <a href=\"topic.htm?path=supraventricular-arrhythmias-after-myocardial-infarction#H2\" class=\"medical medical_review\">&quot;Supraventricular arrhythmias after myocardial infarction&quot;, section on 'Sinus bradycardia'</a> and <a href=\"#H389674433\" class=\"local\">'Myocardial ischemia'</a> below.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Bowel or bladder distention after abdominal surgery</strong> &ndash; Visceral distention of the bowel or bladder may initiate a vagal reflex, causing bradycardia.</p><p/><p class=\"headingAnchor\" id=\"H30660453\"><span class=\"h2\">Atrial tachyarrhythmias</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For atrial tachyarrhythmias causing hemodynamic instability (eg, hypotension, myocardial ischemia, pulmonary edema), urgent cardioversion is recommended, unless it is certain that the rhythm is sinus tachycardia (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 3</a>).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Sinus tachycardia</strong> &ndash; Sinus tachycardia with HR &gt;100 bpm is common in the PACU due to:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Pain</strong> &ndash; hypertension typically also present (see <a href=\"#H604297388\" class=\"local\">'Noxious stimuli'</a> above).</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Hypovolemia</strong> &ndash; hypotension typically also present (see <a href=\"#H64268415\" class=\"local\">'Hypovolemia'</a> above).</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Anemia</strong> &ndash; hypotension typically also present (see <a href=\"#H414114473\" class=\"local\">'Blood loss'</a> above).</p><p/><p class=\"bulletIndent1\">For most patients with mild sinus tachycardia (ie, HR 100 to 120 bpm), treatment of the underlying causes is adequate.</p><p/><p class=\"bulletIndent1\">For patients with known or possible ischemic heart disease or those with HR &gt;120 bpm, sinus tachycardia is treated with an IV beta blocker (eg, bolus doses of <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a> 10 to 25 mg or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a> 1 to 5 mg) to decrease HR to &le;80 bpm, provided that blood pressure (BP) is adequate and there are no contraindications.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Atrial fibrillation</strong> &ndash; Atrial fibrillation (AF) is a narrow complex irregular arrhythmia (<a href=\"image.htm?imageKey=CARD%2F73958\" class=\"graphic graphic_waveform graphicRef73958 \">waveform 1</a> and <a href=\"image.htm?imageKey=CARD%2F53988\" class=\"graphic graphic_waveform graphicRef53988 \">waveform 2</a>). Risk factors include preexisting AF or ischemic heart disease, while specific factors in the PACU include increased sympathetic activity due to operative stress, hypoxia, pain, acute anemia, or myocardial irritability caused by procedures performed near the heart (eg, pulmonary or esophageal surgery) [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/37,38\" class=\"abstract_t\">37,38</a>]. Treatment of AF depends upon hemodynamic stability (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 3</a>). (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H12\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Tachycardia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Regular supraventricular tachycardia </strong>&ndash; Treatment of regular supraventricular tachycardia (SVT) with either narrow (&lt;120 milliseconds) or wide (&ge;120 milliseconds) QRS complex depends on hemodynamic stability (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 3</a>). For stable patients with regular, narrow complex SVT, vagal maneuvers are attempted, followed by administration of adenosine 6 mg rapid IV push. If cardioversion does not occur, adenosine 12 mg rapid IV push is administered, and this 12 mg dose may be repeated once. Expert consultation is recommended for all patients with wide complex tachycardia as soon as possible [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/32,39\" class=\"abstract_t\">32,39</a>]. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H14\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Regular narrow complex'</a> and <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H16\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Regular wide complex'</a>.) </p><p/><p>Further details regarding management of atrial tachyarrhythmias can be found elsewhere:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H12\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Tachycardia'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias\" class=\"medical medical_review\">&quot;Overview of the acute management of tachyarrhythmias&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=reentry-and-the-development-of-cardiac-arrhythmias\" class=\"medical medical_review\">&quot;Reentry and the development of cardiac arrhythmias&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=wide-qrs-complex-tachycardias-approach-to-management\" class=\"medical medical_review\">&quot;Wide QRS complex tachycardias: Approach to management&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1266501278\"><span class=\"h2\">Ventricular tachyarrhythmias</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Premature ventricular contractions </strong>&ndash; Premature ventricular contractions (PVCs) are relatively common in the PACU due to increased sympathetic stimulation; they typically resolve without treatment.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Ventricular fibrillation, flutter, or monomorphic ventricular tachycardia </strong>&ndash; Ventricular fibrillation, flutter, or monomorphic ventricular tachycardia (<a href=\"image.htm?imageKey=CARD%2F80454\" class=\"graphic graphic_waveform graphicRef80454 \">waveform 3</a> and <a href=\"image.htm?imageKey=CARD%2F65800\" class=\"graphic graphic_waveform graphicRef65800 \">waveform 4</a> and <a href=\"image.htm?imageKey=CARD%2F63176\" class=\"graphic graphic_waveform graphicRef63176 \">waveform 5</a>) requires initiation of cardiopulmonary resuscitation (CPR) and immediate defibrillation as the first steps in the advanced cardiac life support (ACLS) guidelines (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 4</a>). (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H8\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Ventricular fibrillation and pulseless ventricular tachycardia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Polymorphic ventricular tachycardia (torsades de pointes)</strong> &ndash; Torsades de pointes is an irregular polymorphic ventricular tachycardia associated with a prolonged QT interval (<a href=\"image.htm?imageKey=CARD%2F53891\" class=\"graphic graphic_waveform graphicRef53891 \">waveform 6</a>). If the patient loses consciousness or the rhythm degenerates into ventricular fibrillation, ACLS with CPR is initiated and immediate defibrillation is performed. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H17\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Irregular wide complex'</a>.)</p><p/><p class=\"bulletIndent1\">The management of the stable conscious patient having recurrent episodes of torsades de pointes is discussed separately. (See <a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias#H16\" class=\"medical medical_review\">&quot;Overview of the acute management of tachyarrhythmias&quot;, section on 'Polymorphic ventricular tachycardia'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H389674426\"><span class=\"h1\">CARDIOVASCULAR COMPLICATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Myocardial ischemia or decompensated heart failure (HF) may occur in the post-anesthesia care unit (PACU) with or without associated hemodynamic instability (eg, hypotension, hypertension, arrhythmias).</p><p class=\"headingAnchor\" id=\"H389674433\"><span class=\"h2\">Myocardial ischemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients at high risk for perioperative myocardial ischemia or infarction include those having in-hospital surgery with one or more additional risk factors in the revised cardiac risk score (<a href=\"image.htm?imageKey=CARD%2F57075\" class=\"graphic graphic_table graphicRef57075 \">table 4</a>). (See <a href=\"topic.htm?path=perioperative-myocardial-infarction-or-injury-after-noncardiac-surgery\" class=\"medical medical_review\">&quot;Perioperative myocardial infarction or injury after noncardiac surgery&quot;</a>.)</p><p>The highest-risk patients are those having urgent or emergent surgery with:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Recent myocardial infarction or unstable angina [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/22\" class=\"abstract_t\">22</a>]. (See <a href=\"topic.htm?path=evaluation-of-cardiac-risk-prior-to-noncardiac-surgery#H418242309\" class=\"medical medical_review\">&quot;Evaluation of cardiac risk prior to noncardiac surgery&quot;, section on 'Very high-risk patients'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Recent percutaneous coronary intervention (PCI), particularly if dual antiplatelet therapy was prematurely discontinued for surgery. (See <a href=\"topic.htm?path=noncardiac-surgery-after-percutaneous-coronary-intervention\" class=\"medical medical_review\">&quot;Noncardiac surgery after percutaneous coronary intervention&quot;</a>.)</p><p/><p>In high-risk patients, continuous electrocardiography (ECG) monitoring for myocardial ischemia includes multiple leads (eg, II and V<sub>5</sub>) and computerized ST-segment analysis, if available in the PACU. Other recommendations for screening for myocardial ischemia in high-risk patients are discussed separately. (See <a href=\"topic.htm?path=perioperative-myocardial-infarction-or-injury-after-noncardiac-surgery#H530579546\" class=\"medical medical_review\">&quot;Perioperative myocardial infarction or injury after noncardiac surgery&quot;, section on 'Screening'</a>.)</p><p>Optimal myocardial oxygen (O<sub>2</sub>) supply and minimal O<sub>2</sub> demand are achieved by maintaining a low to normal heart rate, normal to high blood pressure (BP), and adequate arterial oxygen content, as well as avoiding hypothermia and fluid overload (<a href=\"image.htm?imageKey=ANEST%2F91907\" class=\"graphic graphic_table graphicRef91907 \">table 5</a>). (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H213850611\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Prevention of ischemia'</a>.)</p><p>In patients with symptoms or signs suggestive of myocardial ischemia, we recommend obtaining a 12-lead ECG and troponin measurements. If available, bedside transthoracic echocardiography can be used to quickly detect regional wall motion abnormalities. Also, a cardiologist is consulted since urgent subspecialist interventions will be necessary if an acute coronary syndrome is developing (<a href=\"image.htm?imageKey=CARD%2F75032\" class=\"graphic graphic_table graphicRef75032 \">table 6</a>). The diagnosis and management of perioperative myocardial infarction are discussed separately. (See <a href=\"topic.htm?path=perioperative-myocardial-infarction-or-injury-after-noncardiac-surgery\" class=\"medical medical_review\">&quot;Perioperative myocardial infarction or injury after noncardiac surgery&quot;</a> and <a href=\"topic.htm?path=role-of-echocardiography-in-acute-myocardial-infarction\" class=\"medical medical_review\">&quot;Role of echocardiography in acute myocardial infarction&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H851427634\"><span class=\"h2\">Decompensated heart failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients at increased risk for development of acute HF in the immediate postoperative period include those with a history of chronic left or right HF, as well as those with diastolic HF (also called HF with preserved ejection fraction). This is due to intraoperative factors such as fluid overload resulting from fluid shifts during major surgery, anemia, myocardial ischemia, severe hypertension, stress-induced (Takotsubo) cardiomyopathy, or prolonged unfavorable surgical positioning (eg, supine positioning of a patient who cannot tolerate this position while awake). (See <a href=\"topic.htm?path=perioperative-management-of-heart-failure-in-patients-undergoing-noncardiac-surgery#H27556641\" class=\"medical medical_review\">&quot;Perioperative management of heart failure in patients undergoing noncardiac surgery&quot;, section on 'Postoperative management'</a>.)</p><p>Acute HF typically manifests as respiratory distress with or without overt pulmonary edema. Respiratory distress may be accompanied by hypertension due to hypervolemia or hypotension due to cardiogenic shock or excess vasodilator use. (See <a href=\"topic.htm?path=approach-to-acute-decompensated-heart-failure-in-adults\" class=\"medical medical_review\">&quot;Approach to acute decompensated heart failure in adults&quot;</a>.)</p><p>Treatment for acute decompensated HF incudes (<a href=\"image.htm?imageKey=EM%2F75041\" class=\"graphic graphic_table graphicRef75041 \">table 7</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Administration of supplemental O<sub>2</sub>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For persistent respiratory distress, respiratory acidosis, <span class=\"nowrap\">and/or</span> hypoxia despite oxygen therapy, initiation of noninvasive ventilation (NIV) or endotracheal intubation and mechanical ventilation, as indicated. (See <a href=\"topic.htm?path=noninvasive-ventilation-in-acute-respiratory-failure-in-adults#H16\" class=\"medical medical_review\">&quot;Noninvasive ventilation in acute respiratory failure in adults&quot;, section on 'Cardiogenic pulmonary edema'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Administration of intravenous (IV) diuretics to relieve pulmonary congestion or fluid overload [<a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/40\" class=\"abstract_t\">40</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Initiation of vasodilator therapy in the following settings: early IV <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a> as a component of therapy in patients with refractory HF (eg, inadequate response to diuretics <span class=\"nowrap\">and/or</span> low cardiac output), or IV <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> as arterial vasodilator therapy to reduce afterload in patients with severe hypertension (<a href=\"image.htm?imageKey=NEPH%2F64066\" class=\"graphic graphic_table graphicRef64066 \">table 3</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Initiation of an inotropic infusion (eg, <a href=\"topic.htm?path=milrinone-drug-information\" class=\"drug drug_general\">milrinone</a> or <a href=\"topic.htm?path=dobutamine-drug-information\" class=\"drug drug_general\">dobutamine</a>) in patients with known systolic HF and signs of cardiogenic shock, in combination with a vasopressor (eg, norepinephrine) if necessary to maintain systemic BP.</p><p/><p>If symptoms do not rapidly resolve in the PACU, a cardiologist or other specialist (eg, an intensivist) is consulted to arrange further management and transfer to an intensive care unit (ICU). Details regarding management of acute decompensated HF are available elsewhere. (See <a href=\"topic.htm?path=treatment-of-acute-decompensated-heart-failure-components-of-therapy\" class=\"medical medical_review\">&quot;Treatment of acute decompensated heart failure: Components of therapy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2854599143\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypotension in the post-anesthesia care unit (PACU) is treated when systolic blood pressure (BP) is &lt;90 mmHg or has decreased &gt;20 percent of baseline, or if the patient develops symptoms or other evidence of hypoperfusion (eg, change in mental status or decreased urine output). (See <a href=\"#H30658124\" class=\"local\">'Initial assessment and treatment'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Initial treatment includes intravenous (IV) isotonic crystalloid solution administered in 250- to 500-mL increments and, if necessary, IV <span class=\"nowrap\">vasopressor/inotropic</span> agents (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> 40 to 100 mcg or <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> 5 to 10 mg increments). Severe or refractory hypotension is treated with IV bolus doses of <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> 10 to 50 mcg, norepinephrine 4 to 16 mcg, or vasopressin 1 to 4 units, while a <span class=\"nowrap\">vasopressor/inotropic</span> infusion is prepared (<a href=\"image.htm?imageKey=PULM%2F99963\" class=\"graphic graphic_table graphicRef99963 \">table 1</a>). (See <a href=\"#H30658124\" class=\"local\">'Initial assessment and treatment'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Additional treatment of hypotension depends upon the specific etiology (eg, hypovolemia due to inadequate fluid replacement or blood loss, drug effects due to antihypertensive or anesthetic agents, allergic reaction, adrenal insufficiency, myocardial dysfunction). (See <a href=\"#H30659896\" class=\"local\">'Treatment of underlying causes'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Severe hypotension or hemodynamic collapse requiring immediate lifesaving intervention may occur due to anaphylactic shock, septic shock, local anesthetic toxicity, tension pneumothorax, pulmonary embolus, cardiac tamponade, or dynamic left ventricular outflow tract obstruction. Support with <span class=\"nowrap\">vasopressor/inotropic</span> agents is necessary while definitive treatment is underway (<a href=\"image.htm?imageKey=PULM%2F99963\" class=\"graphic graphic_table graphicRef99963 \">table 1</a>). (See <a href=\"#H604297531\" class=\"local\">'Hypotensive emergencies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypertension is typically treated when systolic BP is &gt;180 mmHg or diastolic BP is &gt;110 mmHg, particularly if it persists after treatment of presumed etiologies. (See <a href=\"#H30658945\" class=\"local\">'Initial assessment and treatment'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Initial treatment is with small bolus doses of rapid-acting antihypertensive agents such as <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a> 5 to 20 mg, titrated to decrease systolic BP to a stable value &lt;160 mmHg. <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">Metoprolol</a> or labetalol are preferred for treating hypertension associated with tachycardia due to their beta-blocking properties. For severe or refractory hypertension, a vasodilator infusion is prepared (<a href=\"image.htm?imageKey=NEPH%2F64066\" class=\"graphic graphic_table graphicRef64066 \">table 3</a>). (See <a href=\"#H30658945\" class=\"local\">'Initial assessment and treatment'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Additional treatment of hypertension depends upon the specific etiology (eg, poorly controlled preexisting hypertension; sympathetic stimulation due to pain or other noxious stimuli; hypervolemia; alcohol or opioid withdrawal; recent use of cocaine, amphetamine, or phencyclidine). (See <a href=\"#H30660184\" class=\"local\">'Treatment of underlying causes'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Emergency treatment of severe hypertension is warranted if there is evidence of acute neurologic signs or symptoms (eg, agitation, delirium, stupor, visual disturbances, seizures, stroke) or a cardiovascular emergency (eg, acute coronary syndrome, acute decompensated heart failure [HF], aortic dissection) (<a href=\"image.htm?imageKey=NEPH%2F64066\" class=\"graphic graphic_table graphicRef64066 \">table 3</a>). (See <a href=\"topic.htm?path=drugs-used-for-the-treatment-of-hypertensive-emergencies\" class=\"medical medical_review\">&quot;Drugs used for the treatment of hypertensive emergencies&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe bradycardia or tachyarrhythmias causing hemodynamic instability require emergency treatment. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H7\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Management of specific arrhythmias'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Underlying causes should be identified and treated. (See <a href=\"#H604297430\" class=\"local\">'Cardiac arrhythmias'</a> above and <a href=\"#H30659097\" class=\"local\">'Assessment and treatment of underlying causes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myocardial ischemia or decompensated HF may occur in the PACU with or without associated hemodynamic instability (eg, hypotension, hypertension, arrhythmias). (See <a href=\"topic.htm?path=perioperative-myocardial-infarction-or-injury-after-noncardiac-surgery\" class=\"medical medical_review\">&quot;Perioperative myocardial infarction or injury after noncardiac surgery&quot;</a> and <a href=\"topic.htm?path=perioperative-management-of-heart-failure-in-patients-undergoing-noncardiac-surgery\" class=\"medical medical_review\">&quot;Perioperative management of heart failure in patients undergoing noncardiac surgery&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/1\" class=\"nounderline abstract_t\">Hines R, Barash PG, Watrous G, O'Connor T. Complications occurring in the postanesthesia care unit: a survey. Anesth Analg 1992; 74:503.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/2\" class=\"nounderline abstract_t\">Rose DK, Cohen MM, DeBoer DP. Cardiovascular events in the postanesthesia care unit: contribution of risk factors. Anesthesiology 1996; 84:772.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/3\" class=\"nounderline abstract_t\">Kluger MT, Bullock MF. Recovery room incidents: a review of 419 reports from the Anaesthetic Incident Monitoring Study (AIMS). Anaesthesia 2002; 57:1060.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/4\" class=\"nounderline abstract_t\">Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 2007; 107:213.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/5\" class=\"nounderline abstract_t\">Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/6\" class=\"nounderline abstract_t\">Mark JB. Central venous pressure monitoring: clinical insights beyond the numbers. J Cardiothorac Vasc Anesth 1991; 5:163.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/7\" class=\"nounderline abstract_t\">Solon JG, Egan C, McNamara DA. Safe surgery: how accurate are we at predicting intra-operative blood loss? J Eval Clin Pract 2013; 19:100.</a></li><li class=\"breakAll\">Romazicon [package insert]. Basel, Switzerland: Roche Pharmaceuticals; 1994</li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/9\" class=\"nounderline abstract_t\">Taff RH. Pulmonary edema following naloxone administration in a patient without heart disease. Anesthesiology 1983; 59:576.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/10\" class=\"nounderline abstract_t\">Klasen J, Junger A, Hartmann B, et al. Differing incidences of relevant hypotension with combined spinal-epidural anesthesia and spinal anesthesia. Anesth Analg 2003; 96:1491.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/11\" class=\"nounderline abstract_t\">Berroa F, Lafuente A, Javaloyes G, et al. The incidence of perioperative hypersensitivity reactions: a single-center, prospective, cohort study. Anesth Analg 2015; 121:117.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/12\" class=\"nounderline abstract_t\">Gurrieri C, Weingarten TN, Martin DP, et al. Allergic reactions during anesthesia at a large United States referral center. Anesth Analg 2011; 113:1202.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/13\" class=\"nounderline abstract_t\">Lonjaret L, Lairez O, Minville V, Geeraerts T. Optimal perioperative management of arterial blood pressure. Integr Blood Press Control 2014; 7:49.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/14\" class=\"nounderline abstract_t\">Aronson S, Varon J. Hemodynamic control and clinical outcomes in the perioperative setting. J Cardiothorac Vasc Anesth 2011; 25:509.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/15\" class=\"nounderline abstract_t\">Myklejord DJ. Undiagnosed pheochromocytoma: the anesthesiologist nightmare. Clin Med Res 2004; 2:59.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/16\" class=\"nounderline abstract_t\">Sheinberg R, Gao WD, Wand G, et al. Case 1--2012. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management. J Cardiothorac Vasc Anesth 2012; 26:161.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/17\" class=\"nounderline abstract_t\">O'Riordan JA. Pheochromocytomas and anesthesia. Int Anesthesiol Clin 1997; 35:99.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/18\" class=\"nounderline abstract_t\">Gal TJ, Cooperman LH. Hypertension in the immediate postoperative period. Br J Anaesth 1975; 47:70.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/19\" class=\"nounderline abstract_t\">Colson P, Saussine M, S&eacute;guin JR, et al. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1992; 74:805.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/20\" class=\"nounderline abstract_t\">Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81:299.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/21\" class=\"nounderline abstract_t\">Ghadimi K, Thompson A. Update on perioperative care of the cardiac patient for noncardiac surgery. Curr Opin Anaesthesiol 2015; 28:342.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/22\" class=\"nounderline abstract_t\">Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:2215.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/23\" class=\"nounderline abstract_t\">Radtke FM, Franck M, Hagemann L, et al. Risk factors for inadequate emergence after anesthesia: emergence delirium and hypoactive emergence. Minerva Anestesiol 2010; 76:394.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/24\" class=\"nounderline abstract_t\">Bitsch M, Foss N, Kristensen B, Kehlet H. Pathogenesis of and management strategies for postoperative delirium after hip fracture: a review. Acta Orthop Scand 2004; 75:378.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/25\" class=\"nounderline abstract_t\">Frank SM, Fleisher LA, Olson KF, et al. Multivariate determinants of early postoperative oxygen consumption in elderly patients. Effects of shivering, body temperature, and gender. Anesthesiology 1995; 83:241.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/26\" class=\"nounderline abstract_t\">Sun KO. Severe postoperative shivering and hypoglycaemia. Anaesth Intensive Care 1993; 21:873.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/27\" class=\"nounderline abstract_t\">De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology 2002; 96:467.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/28\" class=\"nounderline abstract_t\">Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997; 277:1127.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/29\" class=\"nounderline abstract_t\">Lenhardt R, Marker E, Goll V, et al. Mild intraoperative hypothermia prolongs postanesthetic recovery. Anesthesiology 1997; 87:1318.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/30\" class=\"nounderline abstract_t\">Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology 2009; 110:1139.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/31\" class=\"nounderline abstract_t\">Dal Mago AJ, Helayel PE, Bianchini E, et al. Prevalence and predictive factors of urinary retention assessed by ultrasound in the immediate post-anesthetic period. Rev Bras Anestesiol 2010; 60:383.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/32\" class=\"nounderline abstract_t\">Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015; 132:S444.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/33\" class=\"nounderline abstract_t\">Gratadour P, Viale JP, Parlow J, et al. Sympathovagal effects of spinal anesthesia assessed by the spontaneous cardiac baroreflex. Anesthesiology 1997; 87:1359.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/34\" class=\"nounderline abstract_t\">Lesser JB, Sanborn KV, Valskys R, Kuroda M. Severe bradycardia during spinal and epidural anesthesia recorded by an anesthesia information management system. Anesthesiology 2003; 99:859.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/35\" class=\"nounderline abstract_t\">Caplan RA, Ward RJ, Posner K, Cheney FW. Unexpected cardiac arrest during spinal anesthesia: a closed claims analysis of predisposing factors. Anesthesiology 1988; 68:5.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/36\" class=\"nounderline abstract_t\">Keats AS. Anesthesia mortality--a new mechanism. Anesthesiology 1988; 68:2.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/37\" class=\"nounderline abstract_t\">Bhave PD, Goldman LE, Vittinghoff E, et al. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 2012; 164:918.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/38\" class=\"nounderline abstract_t\">Danelich IM, Lose JM, Wright SS, et al. Practical management of postoperative atrial fibrillation after noncardiac surgery. J Am Coll Surg 2014; 219:831.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/39\" class=\"nounderline abstract_t\">Link MS, Atkins DL, Passman RS, et al. Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S706.</a></li><li><a href=\"https://www.uptodate.com/contents/cardiovascular-problems-in-the-post-anesthesia-care-unit-pacu/abstract/40\" class=\"nounderline abstract_t\">WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128:e240.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 94349 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2854599143\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H260101484\" id=\"outline-link-H260101484\">INTRODUCTION</a></li><li><a href=\"#H604297284\" id=\"outline-link-H604297284\">HYPOTENSION</a><ul><li><a href=\"#H30658124\" id=\"outline-link-H30658124\">Initial assessment and treatment</a></li><li><a href=\"#H30659896\" id=\"outline-link-H30659896\">Treatment of underlying causes</a><ul><li><a href=\"#H64268415\" id=\"outline-link-H64268415\">- Hypovolemia</a><ul><li><a href=\"#H414114555\" id=\"outline-link-H414114555\">Inadequate fluid replacement</a></li><li><a href=\"#H414114473\" id=\"outline-link-H414114473\">Blood loss</a></li></ul></li><li><a href=\"#H30658136\" id=\"outline-link-H30658136\">- Drug effects</a><ul><li><a href=\"#H30658180\" id=\"outline-link-H30658180\">Antihypertensive agents</a></li><li><a href=\"#H470507396\" id=\"outline-link-H470507396\">Anesthetic agents</a></li></ul></li><li><a href=\"#H680092306\" id=\"outline-link-H680092306\">- Sympathectomy due to neuraxial block</a></li><li><a href=\"#H292870340\" id=\"outline-link-H292870340\">- Allergic (hypersensitivity) reaction</a><ul><li><a href=\"#H470507432\" id=\"outline-link-H470507432\">Drug allergy and anaphylaxis</a></li><li><a href=\"#H443892235\" id=\"outline-link-H443892235\">Transfusion reaction</a></li></ul></li><li><a href=\"#H443893336\" id=\"outline-link-H443893336\">- Adrenal insufficiency</a></li><li><a href=\"#H64268736\" id=\"outline-link-H64268736\">- Myocardial dysfunction</a></li></ul></li><li><a href=\"#H604297531\" id=\"outline-link-H604297531\">Hypotensive emergencies</a></li></ul></li><li><a href=\"#H604297382\" id=\"outline-link-H604297382\">HYPERTENSION</a><ul><li><a href=\"#H30658945\" id=\"outline-link-H30658945\">Initial assessment and treatment</a></li><li><a href=\"#H1047418413\" id=\"outline-link-H1047418413\">Hypertensive emergencies</a></li><li><a href=\"#H30660184\" id=\"outline-link-H30660184\">Treatment of underlying causes</a><ul><li><a href=\"#H416807755\" id=\"outline-link-H416807755\">- Preexisting hypertension</a></li><li><a href=\"#H604297388\" id=\"outline-link-H604297388\">- Noxious stimuli</a></li><li><a href=\"#H307120786\" id=\"outline-link-H307120786\">- Hypervolemia</a></li><li><a href=\"#H924151517\" id=\"outline-link-H924151517\">- Use of alcohol, opioids, and other drugs</a></li></ul></li></ul></li><li><a href=\"#H604297430\" id=\"outline-link-H604297430\">CARDIAC ARRHYTHMIAS</a><ul><li><a href=\"#H604297436\" id=\"outline-link-H604297436\">Bradycardia</a><ul><li><a href=\"#H30659091\" id=\"outline-link-H30659091\">- Initial treatment</a></li><li><a href=\"#H30659097\" id=\"outline-link-H30659097\">- Assessment and treatment of underlying causes</a></li></ul></li><li><a href=\"#H30660453\" id=\"outline-link-H30660453\">Atrial tachyarrhythmias</a></li><li><a href=\"#H1266501278\" id=\"outline-link-H1266501278\">Ventricular tachyarrhythmias</a></li></ul></li><li><a href=\"#H389674426\" id=\"outline-link-H389674426\">CARDIOVASCULAR COMPLICATIONS</a><ul><li><a href=\"#H389674433\" id=\"outline-link-H389674433\">Myocardial ischemia</a></li><li><a href=\"#H851427634\" id=\"outline-link-H851427634\">Decompensated heart failure</a></li></ul></li><li><a href=\"#H2854599143\" id=\"outline-link-H2854599143\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ANEST/94349|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=PULM/99762\" class=\"graphic graphic_algorithm\">- Hemodynamically unstable PE treatment algorithm</a></li><li><a href=\"image.htm?imageKey=EM/63919\" class=\"graphic graphic_algorithm\">- Adult bradycardia algorithm</a></li><li><a href=\"image.htm?imageKey=EM/62714\" class=\"graphic graphic_algorithm\">- Adult tachycardia algorithm</a></li><li><a href=\"image.htm?imageKey=EM/73862\" class=\"graphic graphic_algorithm\">- Adult cardiac arrest algorithm</a></li></ul></li><li><div id=\"ANEST/94349|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/99963\" class=\"graphic graphic_table\">- Vasopressors and inotropes</a></li><li><a href=\"image.htm?imageKey=HEME/93934\" class=\"graphic graphic_table\">- Transfusion thresholds adult</a></li><li><a href=\"image.htm?imageKey=NEPH/64066\" class=\"graphic graphic_table\">- Drugs for hypertensive emergencies</a></li><li><a href=\"image.htm?imageKey=CARD/57075\" class=\"graphic graphic_table\">- Revised cardiac risk index</a></li><li><a href=\"image.htm?imageKey=ANEST/91907\" class=\"graphic graphic_table\">- Factors governing O2 supply and demand in myocardial ischemia</a></li><li><a href=\"image.htm?imageKey=CARD/75032\" class=\"graphic graphic_table\">- Rapid overview: Management of acute coronary syndrome (ACS)</a></li><li><a href=\"image.htm?imageKey=EM/75041\" class=\"graphic graphic_table\">- Rapid overview acute decompensated heart failure</a></li></ul></li><li><div id=\"ANEST/94349|Waveform\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"WAVEFORMS\">WAVEFORMS</a></div><ul><li><a href=\"image.htm?imageKey=CARD/73958\" class=\"graphic graphic_waveform\">- ECG atrial fibrillation 1</a></li><li><a href=\"image.htm?imageKey=CARD/53988\" class=\"graphic graphic_waveform\">- ECG atrial fibrillation 2</a></li><li><a href=\"image.htm?imageKey=CARD/80454\" class=\"graphic graphic_waveform\">- ECG Ventricular fibrillation tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/65800\" class=\"graphic graphic_waveform\">- Ventricular flutter tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/63176\" class=\"graphic graphic_waveform\">- ECG Monomorphic VT tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/53891\" class=\"graphic graphic_waveform\">- ECG Torsades de pointes tutorial</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-amphetamine-and-synthetic-cathinone-bath-salt-intoxication\" class=\"medical medical_review\">Acute amphetamine and synthetic cathinone (&quot;bath salt&quot;) intoxication</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-opioid-intoxication-in-adults\" class=\"medical medical_review\">Acute opioid intoxication in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults\" class=\"medical medical_review\">Advanced cardiac life support (ACLS) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anaphylaxis-emergency-treatment\" class=\"medical medical_review\">Anaphylaxis: Emergency treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease\" class=\"medical medical_review\">Anesthesia for noncardiac surgery in patients with ischemic heart disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-the-adult-with-pheochromocytoma\" class=\"medical medical_review\">Anesthesia for the adult with pheochromocytoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-acute-decompensated-heart-failure-in-adults\" class=\"medical medical_review\">Approach to acute decompensated heart failure in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-a-suspected-acute-transfusion-reaction\" class=\"medical medical_review\">Approach to the patient with a suspected acute transfusion reaction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atrial-fibrillation-and-flutter-after-cardiac-surgery\" class=\"medical medical_review\">Atrial fibrillation and flutter after cardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=benzodiazepine-poisoning-and-withdrawal\" class=\"medical medical_review\">Benzodiazepine poisoning and withdrawal</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiac-tamponade\" class=\"medical medical_review\">Cardiac tamponade</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-hypokalemia-in-adults\" class=\"medical medical_review\">Clinical manifestations and treatment of hypokalemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia\" class=\"medical medical_review\">Clinical use of neuromuscular blocking agents in anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cocaine-acute-intoxication\" class=\"medical medical_review\">Cocaine: Acute intoxication</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=delayed-emergence-and-emergence-delirium-in-adults\" class=\"medical medical_review\">Delayed emergence and emergence delirium in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drugs-used-for-the-treatment-of-hypertensive-emergencies\" class=\"medical medical_review\">Drugs used for the treatment of hypertensive emergencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-management-of-suspected-sepsis-and-septic-shock-in-adults\" class=\"medical medical_review\">Evaluation and management of suspected sepsis and septic shock in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-treatment-of-hypertensive-emergencies-in-adults\" class=\"medical medical_review\">Evaluation and treatment of hypertensive emergencies in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-and-initial-approach-to-the-adult-patient-with-undifferentiated-hypotension-and-shock\" class=\"medical medical_review\">Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-cardiac-risk-prior-to-noncardiac-surgery\" class=\"medical medical_review\">Evaluation of cardiac risk prior to noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypertrophic-cardiomyopathy-medical-therapy\" class=\"medical medical_review\">Hypertrophic cardiomyopathy: Medical therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intraoperative-fluid-management\" class=\"medical medical_review\">Intraoperative fluid management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intraoperative-transfusion-of-blood-products-in-adults\" class=\"medical medical_review\">Intraoperative transfusion of blood products in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-acute-perioperative-pain\" class=\"medical medical_review\">Management of acute perioperative pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-moderate-and-severe-alcohol-withdrawal-syndromes\" class=\"medical medical_review\">Management of moderate and severe alcohol withdrawal syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-severe-asymptomatic-hypertension-hypertensive-urgencies-in-adults\" class=\"medical medical_review\">Management of severe asymptomatic hypertension (hypertensive urgencies) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=noncardiac-surgery-after-percutaneous-coronary-intervention\" class=\"medical medical_review\">Noncardiac surgery after percutaneous coronary intervention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=noninvasive-ventilation-in-acute-respiratory-failure-in-adults\" class=\"medical medical_review\">Noninvasive ventilation in acute respiratory failure in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=opioid-withdrawal-in-the-emergency-setting\" class=\"medical medical_review\">Opioid withdrawal in the emergency setting</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-peripheral-nerve-blocks\" class=\"medical medical_review\">Overview of peripheral nerve blocks</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-post-anesthetic-care-for-adult-patients\" class=\"medical medical_review\">Overview of post-anesthetic care for adult patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias\" class=\"medical medical_review\">Overview of the acute management of tachyarrhythmias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-anaphylaxis-clinical-manifestations-etiology-and-management\" class=\"medical medical_review\">Perioperative anaphylaxis: Clinical manifestations, etiology, and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-management-of-heart-failure-in-patients-undergoing-noncardiac-surgery\" class=\"medical medical_review\">Perioperative management of heart failure in patients undergoing noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-management-of-hypertension\" class=\"medical medical_review\">Perioperative management of hypertension</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-myocardial-infarction-or-injury-after-noncardiac-surgery\" class=\"medical medical_review\">Perioperative myocardial infarction or injury after noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-adults\" class=\"medical medical_review\">Phencyclidine (PCP) intoxication in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postoperative-complications-among-patients-undergoing-cardiac-surgery\" class=\"medical medical_review\">Postoperative complications among patients undergoing cardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postoperative-nausea-and-vomiting\" class=\"medical medical_review\">Postoperative nausea and vomiting</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=reentry-and-the-development-of-cardiac-arrhythmias\" class=\"medical medical_review\">Reentry and the development of cardiac arrhythmias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=respiratory-problems-in-the-post-anesthesia-care-unit-pacu\" class=\"medical medical_review\">Respiratory problems in the post-anesthesia care unit (PACU)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=role-of-echocardiography-in-acute-myocardial-infarction\" class=\"medical medical_review\">Role of echocardiography in acute myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sinus-bradycardia\" class=\"medical medical_review\">Sinus bradycardia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=supraventricular-arrhythmias-after-myocardial-infarction\" class=\"medical medical_review\">Supraventricular arrhythmias after myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-acute-decompensated-heart-failure-components-of-therapy\" class=\"medical medical_review\">Treatment of acute decompensated heart failure: Components of therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-adrenal-insufficiency-in-adults\" class=\"medical medical_review\">Treatment of adrenal insufficiency in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-prognosis-and-follow-up-of-acute-pulmonary-embolism-in-adults\" class=\"medical medical_review\">Treatment, prognosis, and follow-up of acute pulmonary embolism in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=wide-qrs-complex-tachycardias-approach-to-management\" class=\"medical medical_review\">Wide QRS complex tachycardias: Approach to management</a></li></ul></div></div>","javascript":null}